N.Z. Biotech Delays Introducing Xenotransplant Treatment In Russia
This article was originally published in PharmAsia News
Executive Summary
New Zealand biotech Living Cell Technologies said it would delay its launch of a transplant treatment for Russian diabetics for another six months so it has time to educate the local market